News

Deal Announcements

Spiration Garners Venture Capital Debt Funding

Thursday, April 29, 2010 5:53:00 AM PDT | VentureDeal Staff
Redmond, Washington  --  Medical device company Spiration has secured $6.5 million in a new round of venture capital debt financing.

Spiration cells medical devices for the treatment of lung cancer and chronic obstructive pulmonary disease (COPD).

The venture capital lender was not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1